technology
Antengene to Present Latest Preclinical Results of Novel Cos-TCE Platform in Rapid Oral Abstract Presentation at SITC 2026

SHANGHAI and HONG KONG, Oct. 3, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for...
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories

Delhi’s new master plan can soothe parking pains
Hindustan Times

World News | Indian Ambassador to Kazakhstan Calls for ‘connectivity in Its True Sense’, Urges Shift from AI Talks to Joint Projects
Latestly

World News | “I'm Hurting, but Care Deeply About E”: Musk's Partner Shivon Zilis Confirms Sudden Split, Hopes to Be “great Coparents”
Latestly

LIGHT AI PROVIDES QUICKSCAN™ STREP A PRODUCT DEVELOPMENT UPDATE
Techdash.in

CNG drivers, check this before your next refill: IGL’s new system can flag your car at the pump
Business News India